| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeafb6c61146824c44bccb18cf449c35 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aec760f843616b6ef4bdf49231b030e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd47a20595b8f323b608c8b8b974b883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f241bf7a7dc389d0235bbfcd121aab7 |
| publicationDate |
2012-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2401401-A1 |
| titleOfInvention |
A drug identification protocol for type 2 diabetes based on gene expression signatures |
| abstract |
The present invention relates generally to the field of drug identification and evaluation and therapeutic optimization. More particularly, the present invention provides a protocol for identifying compounds useful in the treatment of TNFα associated diabetes or a condition associated with diabetes based on a signature of genomic or proteomic expression. Diagnostic and prognostic protocols for diabetes and conditions associated therewith also form part of the present invention. Optimization of therapeutic intervention is also encompassed by the present invention. |
| priorityDate |
2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |